Zimmer Biomet (ZBH) Stock
NASDAQ · ZBH
95.36
Fundamentals
Market cap
$18.19B
Price / Earnings ratio
22.3x
Price / Sales ratio
2.1x
Price / Book ratio
1.4x
Return on assets
0.0%
Ex-Dividend date
25 Jun 2026
Last payment date
N/A
Dividend amount
$0.24
Dividend yield
1.0%
Debt / Equity ratio
N/A
Latest news
About Zimmer Biomet
Zimmer Biomet has been based in Warsaw since it was founded in 1927. Today, Zimmer Biomet has operations in more than 25 countries around the world and sells products in more than 100 countries. Our global team designs, manufactures and markets effective, innovative solutions that support orthopaedic surgeons and clinicians in alleviating pain and improving the quality of life for people around the world. Our musculoskeletal technologies and a wide range of related products and services make us partners to healthcare providers in more than 100 countries.
SectorHealthcare
IndustryMedical Devices
Employees17,000
CEOMr. Ivan Tornos
IPO DateJul 25, 2001
HeadquartersWarsaw, IN
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Ivan Tornos | President, CEO & Chairman of the Board | 1975 |
| Mr. Wilfred van Zuilen | Group President of Europe, Middle East & Africa | 1970 |
| Mr. JehanZeb Noor | Senior VP, Chief Strategy, Business Development, Innovation & Transformation Officer | 1982 |
| Mr. Kevin R. Thornal | Group President of Global Businesses & Americas | 1974 |
| Mr. Paul A. Stellato | Interim CFO, VP, Controller & Chief Accounting Officer | 1975 |
| Mr. Shaun Braun | Senior VP & Chief Information and Technology Officer | — |
| Dr. Jonathan M. Vigdorchik M.D. | Chief Science, Technology & Medical Affairs Officer | — |
| Mr. David M. DeMartino | Senior Vice President of Investor Relations | — |
| Mr. Chad F. Phipps J.D. | Senior VP, Chief Legal & Corporate Affairs Officer and Secretary | 1972 |
| Ms. Angela Main | Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific | — |
Fundamentals
Valuation
Market cap$18.19B
Price-to-sales ratio2.11
Price-to-book value1.42
Price-earnings ratio22.30
Return on Equity6.00%
Return on Sales0.14%
Return on Assets0.03%
PEG ratio0.64
Earnings Per Share
Earnings Per Share$4.13
Income Statement
Average volume1,670,245
EBITDA$2.31B
1 year high (52w)$106.88
1 year low (52w)$79.12
Dividend
Ex dividend date25 Jun 2026
Dividend amount$0.24
Dividend yield1.01%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



